Primary amyloidosis and acute leukemia associated with melphalan therapy.
D000686:Amyloidosis / Q000188:drug therapy*; D001772:Blood Cell Count; D001792:Blood Platelets; D001803:Blood Transfusion; D001856:Bone Marrow Examination; D002512:Cephalothin / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004912:Erythrocytes; D005839:Gentamicins / Q000627:therapeutic use; D006454:Hemoglobins; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D008558:Melphalan / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011507:Proteinuria; D013866:Thioguanine / Q000627:therapeutic use
D005839:Gentamicins; D006454:Hemoglobins; D003561:Cytarabine; D013866:Thioguanine; D008558:Melphalan; D002512:Cephalothin